Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Albemarle (ALB)

NYSE: ALB · Specialty Chemicals · Charlotte, NC

Our rating: Neutral

Call changed from Cautious to Neutral at $98.37, moderate conviction, November 5, 2026.

Breaks if: The Neutral call would shift Cautious if reported free cash flow falls below $350M in any two consecutive quarterly filings, signaling that the commodity downcycle is biting deeper into cash generation than the current figures suggest. It would shift Positive if revenue returns to year-over-year growth of 10% or more across two consecutive quarters and net income turns positive in that same window, indicating a genuine lithium price recovery feeding through to the bottom line — neither condition is met today.

Key figures

Market value$9.4B
Revenue, last 12 months$6.2B
Net income, last 12 months$682M
Free cash flow, last 12 months$1.4B
Price to earnings13.8×
Free cash flow yield15.4%
Dividend yield2.0%
Operating margin10.0%
Return on equity6.6%
Beta to the S&P 5001.50
Volatility, annualized57.4%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$1.6B18.8%$2.15$325M
June 30, 2026$1.7B31.1%$3.52$638M
March 31, 2026$1.4B32.7%$2.34$248M
December 31, 2025$1.4B15.9%$-3.88$233M
September 30, 2025$1.3B−3.5%$-1.72$223M
June 30, 2025$1.3B−7.0%$-0.16−$129M
March 31, 2025$1.1B−20.9%$0.00$365M
December 31, 2024$1.2B−47.7%$0.29−$347M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

13 ledger entries and 67 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.